 |
인쇄하기
취소
|
GSK denies entry of generic business
The Korean unit of GlaxoSmithKline (GSK) has made it clear that it has no intention to set foot into the local generic business, despite spreading rumors.
“We have nothing to with our headquarters’ acquisition of a generic firm in South Africa,” a company official said.
Novartis Inc. is attempting to improve their market strength and geographical reach through Sandoz Pharma.
The princi...
“We have nothing to with our headquarters’ acquisition of a generic firm in South Africa,” a company official said.
Novartis Inc. is attempting to improve their market strength and geographical reach through Sandoz Pharma.
The princi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.